ArticleOncogenesis2024

The branched N-glycan of PD-L1 predicts immunotherapy responses in patients with recurrent/metastatic HNSCC.

Huai-Cheng Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.